This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
5h investorplace - 1
Netflix (NASDAQ:NFLX) once was the hottest in the FANG group, but now Netflix stock is down 25% off its all time highs. All of FANG has had a tough time leading the market recently, and many market observers blame Facebook (NASDAQ:FB).
FB T NFLX DIS
In my portfolio introduction, I introduced Seeking Alpha to my real money, REIT-heavy portfolio which had 9 positions. Three months later, most of the portfolio has had an amazing quarter and 3 new positions have been added. With my REIT ‘base’ down, I am now looking ahead to opening positions outside of the REIT space. Without further ado, here is how the portfolio is looking as of market close on Friday, August 17th
JCP ARI TWX TWC STWD.WI SHLD BXMT T LADR 511505 CAPITALT STWD ACRE
A funny thing happened between Aug. 16, 2012, when Apple (NASDAQ:AAPL) initiated a $2.65 quarterly dividend, its first since 1995, and today — Apple became a dividend stock.
LOW FOX HD TXN JCP PAG CMCSA NFLX T HON AAPL PKG SBUX DIS
2018-08-16 investorplace - 1
Wednesday’s action is why you never turn your back on the market. Tuesday’s gain not only snaped a three-day losing streak, it hinted that the bigger-picture rally may be rekindled.
INPAP TWX M TWC CMG HRL IP T MU MS
By any measure the stock market is overbought. On both trailing and forward earnings it is expensive, and while just a few stocks have made up most of the gains in the indexes, and value has been shunned, a correction is probably long overdue. With yields still at historic lows despite the increases in the federal funds rate, and the promise of more to come, safe dividend stocks may be a place to hide out in now.
T TWX AEP TWC
424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) SEC File No. 333-209718 This prospectus supplement relates to an effective registration statement under the Securities Act of 1933, but is not complete and may be changed. This prospectus supplement and the accompanying prospectus is
2018-08-15 investorplace - 1
Despite the tiny drop in its daily active users last quarter, Snap (NYSE:SNAP) and Snap stock have many strong, positive catalysts. Moreover, it is definitely not, as some have said, going to disappear like MySpace, and there is a very good chance that it will be acquired in the next year or two.
AMZN T GOOGL VZ GOOG SNAP
Elon Musk is no stranger to making controversial and outlandish comments, and his tweet earlier last week is no exception. As you probably know by now, the perennial entrepreneur announced to his more than 22 million Twitter followers that he is “considering taking Tesla (NASDAQ:TSLA) private at $420.”
BRK.A T TWX TSLA TWC
One popular form of dividend investing involves a group of stocks called dividend aristocrats. Standards of what makes up a dividend aristocrat vary. However, most analysts define it by three criteria. One, they must belong to the S&P 500 index. Two, they meet specific size and liquidity metrics. Three, and most importantly, they must have increased their dividend for 25 or more consecutive years.
IBM PG AMZN DOV.WI T JNJ TSLA CSCO DOV
15h - Asif
Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...
15h - Asif
Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...
16h - Asif
General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...
as of ET